Liver-on-a-chip and Tumor-on-a-chip (OOCs) End-User Survey
Requirement
The client was interested in understanding the end user landscape for liver-on-a-chip and tumor-on-a-chip market in the USA and European Union (EU).
As per the client’s requirements, the scope of the report included the unmet needs of the market pertaining to the following parameters:
Assay throughput
Specificity and reliability of the chip
Price
Cell type
Reusability of the chip
As per the client’s requirements, the scope of the report included the unmet needs of the market pertaining to the following parameters:
Assay throughput
Specificity and reliability of the chip
Price
Cell type
Reusability of the chip
Solution
We delivered a presentation covering:
Future Prospects of Liver-on-a-chip and Tumor-on-a-chip
Unmet Needs OF OOCs With Respect To-
Assay Throughput
Specificity, Reproducibility & Reliability
Price
Cell Type
Reusability
Characteristics Of an Ideal Liver-on-a-chip and Tumor-on-a-chip
Future Prospects of Liver-on-a-chip and Tumor-on-a-chip
Unmet Needs OF OOCs With Respect To-
Assay Throughput
Specificity, Reproducibility & Reliability
Price
Cell Type
Reusability
Characteristics Of an Ideal Liver-on-a-chip and Tumor-on-a-chip
Methodology
Primary Research – The survey was carried out by conducting interviews with personnel who are the key end users of liver-on-a-chip and tumor-on-a-chip models for various experiments on a day-to-day basis.
We contacted research scientists, postdoctoral fellows, bioengineers, toxicologists and pharmacologists from various companies and universities such as Takeda, AstraZeneca, GSK, Harvard University, The Institute of Cancer Research among others to gather information on assay throughput, reproducibility, current and expected pricing and other parameters.
We contacted research scientists, postdoctoral fellows, bioengineers, toxicologists and pharmacologists from various companies and universities such as Takeda, AstraZeneca, GSK, Harvard University, The Institute of Cancer Research among others to gather information on assay throughput, reproducibility, current and expected pricing and other parameters.
Client Benefits and Feedback
The client was happy with the presentation and were able to understand the challenges and unmet needs of the market.